Loading...
In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae.
Journal Title
Antimicrobial agents and chemotherapy
Keywords
Readers/Advisors
Journal Title
Term and Year
Publication Date
2000-04
Book Title
Publication Volume
44
Publication Issue
4
Publication Begin
1112
Publication End
3
Number of pages
Collections
Files
Research Projects
Organizational Units
Journal Issue
Abstract
The in vitro activities of ABT 773, telithromycin (HMR 3647), azithromycin, clarithromycin, erythromycin, and levofloxacin were tested against 20 strains of Chlamydia pneumoniae. The MIC at which 90% of the isolates were inhibited and the minimal bactericidal concentration at which 90% of the isolates were killed by ABT 773 were 0.015 microg/ml (range, 0.008 to 0.015 microg/ml). ABT 773 was the most active antibiotic tested in this study.
Citation
Strigl S, Roblin PM, Reznik T, Hammerschlag MR. In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae. Antimicrob Agents Chemother. 2000 Apr;44(4):1112-3. doi: 10.1128/AAC.44.4.1112-1113.2000. PMID: 10722526; PMCID: PMC89827.